Old Lyme, CT, United States of America

Keith Mccarthy

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovations by Keith McCarthy in Opioid Synthesis

Introduction

Keith McCarthy is an accomplished inventor based in Old Lyme, Connecticut. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of opioids. With a total of three patents to his name, McCarthy's work focuses on improving the processes involved in opioid production.

Latest Patents

McCarthy's latest patents include a process for improved opioid synthesis. This involves compounds and compositions that serve as starting materials or intermediate materials in the preparation of opioids, such as oxycodone and oxymorphone. His patents detail the processes for preparing these compounds and their applications in the formulation of active pharmaceutical ingredients (APIs) and pharmaceutical dosage forms. Furthermore, these innovations are aimed at enhancing the treatment of various medical conditions.

Career Highlights

Keith McCarthy is currently employed at Rhodes Technologies, where he continues to advance his research in opioid synthesis. His expertise in this area has positioned him as a key figure in the development of safer and more effective pharmaceutical products.

Collaborations

Throughout his career, McCarthy has collaborated with notable colleagues, including Stuart James Gebbie and Joshua Robert Giguere. These partnerships have contributed to the success of his innovative projects and the advancement of opioid synthesis techniques.

Conclusion

In summary, Keith McCarthy's work in opioid synthesis represents a significant advancement in pharmaceutical chemistry. His patents and ongoing research continue to impact the field positively, showcasing his dedication to improving medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…